Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

RxSight

Status

Invitation-only

Conditions

Aphakia Cataract

Treatments

Device: Control IOL

Device: Light Adjustable lens (LAL) and Light Delivery Device (LDD)

Study type

Observational

Funder types

Industry

Identifiers

NCT07347379

CSP-1003

Details and patient eligibility

About

This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL and Control IOL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject and study eye with prior participation in the CSP-029 study.

Exclusion criteria

Subjects with serious co-morbid conditions that in the judgment of the investigator makes inclusion in the study not in the best interest of the subject.